News
Wall Street traders sent stocks lower in the run-up to the Federal Reserve decision, with concerns about high valuations ...
Wall Street traders sent stocks lower in the run-up to the Federal Reserve decision, with concerns about high valuations ...
Stocks closed lower Tuesday as investors took a breather from a rally that had pushed major indexes to a series of record ...
Stock futures edged higher on Tuesday (July 29) after the S&P 500 and Nasdaq Composite notched fresh record highs, even as ...
Carvana is scheduled to report earnings after the closing bell Wednesday, with traders expecting a big move from the used car ...
Visa and Mastercard are expected to report higher quarterly profits this week on steady consumer spending, and analysts will ...
Seeking Alpha on MSN12h
Sarepta upgraded to Neutral at J.P. Morgan, Outperform at Oppenheimer
Sarepta Therapeutics ( NASDAQ: SRPT) was upgraded to Neutral from Underweight at J.P. Morgan as it sees FDA's Elevidys hold removal recommendation in ambulatory patients as a clear win.
In a report released today, A.J. Rice from UBS maintained a Hold rating on Centene, with a price target of $31.00. The company’s shares closed last Friday at $28.39. Take advantage of TipRanks Premium ...
16h
Asianet Newsable on MSNCarvana Set Up For Strong Q2, Analysts Say, As Used Car Sales Boom In Trump-Tariff Era
Meanwhile, although it has had little bearing on the company's stock, Chairman Ernest C. Garcia II has been selling his ...
Detailed price information for Oppenheimer Russell 2000 Multifactor ETF (OMFS-A) from The Globe and Mail including charting and trades.
US stocks eked out records Monday in relatively muted trading session as the US and European Union struck a trade pact. The ...
The bank's Michael Wilson, suggested that the odds of this bullish scenario are rising, supported by favorable economic and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results